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ABSTRACT                                                                                                                                                         
MutT homologue 1 (MTH1) removes 
oxidized nucleotides from the nucleotide pool and 
thereby prevents their incorporation into the 
genome and thereby reduces genotoxicity. We 
previously reported that MTH1 is an efficient 
catalyst of O6-methyl-dGTP hydrolysis 
suggesting that MTH1 may also sanitize the 
nucleotide pool from other methylated 
nucleotides. We here show that MTH1 efficiently 
catalyzes the hydrolysis of N6-methyl-dATP to 
N6-methyl-dAMP and further report that N6-
methylation of dATP drastically increases the 
MTH1 activity. We also observed MTH1 activity 
with N6-methyl-ATP, albeit at a lower level. We 
show that N6-methyl-dATP is incorporated into 
DNA in vivo, as indicated by increased N6-
methyl-dA DNA levels in embryos developed 
from MTH1 knock-out zebrafish eggs 
microinjected with N6-methyl-dATP compared 
with noninjected embryos. N6-methyl-dATP 
activity is present in MTH1 homologues from 
distantly related vertebrates, suggesting 
evolutionary conservation and indicating that this 
activity is important. Of note, N6-methyl-dATP 
activity is unique to MTH1 among related 
NUDIX hydrolases. Moreover, we present the
structure of N6-methyl-dAMP–bound human 
MTH1, revealing that the N6-methyl group is 
accommodated within a hydrophobic active-site 
sub-pocket explaining why N6-methyl-dATP is a 
good MTH1 substrate. N6-methylation of DNA 
and RNA has been reported to have epigenetic 
roles and to affect mRNA metabolism. We 
propose that MTH1 acts in concert with adenosine 
deaminase–like protein isoform 1 (ADAL1) to 
prevent incorporation of N6-methyl-(d)ATP into 
DNA and RNA. This would hinder potential 
dysregulation of epigenetic control and RNA 
metabolism via conversion of N6-methyl-(d)ATP 
to N6-methyl-(d)AMP, followed by ADAL1 
catalyzed deamination producing (d)IMP that can 
enter the nucleotide salvage pathway. 
_______________________________________ 
 
Human MutT homologue 1 (MTH1) belongs 
to the NUDIX family of proteins (1) and catalyzes 
the hydrolysis of the oxidized purine nucleoside 
triphosphates 8-oxo-dGTP, 8-oxo-GTP, 2-OH-
dATP and 2-OH-ATP into their corresponding 
monophosphates (2). Removal of oxidized purine 
nucleoside triphosphates from the free nucleotide 
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pool through MTH1 catalysed hydrolysis 
prevents misincorporation of these nucleotides 
into DNA and RNA and reduces genotoxicity (3).  
Cells from MTH1 knockout (MTH1KO) mice 
display a two-fold increased mutation rate. 
However, these mice grow old and a higher tumor 
burden compared to MTH1 wildtype (MTH1WT) 
mice is only observed in old MTH1KO mice, 
suggesting that MTH1 is dispensible in the short 
term under normal conditions (4). Mice that 
overexpress MTH1 live longer, have a better 
memory, are more social at an old age, and have 
lower levels of 8-oxo-dG in their DNA compared 
to both MTH1WT and MTH1KO mice, 
supporting a correlation between 8-oxo-dG levels 
in DNA and aging (5). MTH1 is required for 
cancer cell survival, yet seems to be dispensible 
for growth of untransformed cells (6,7). This is 
thought to be due to the elevated reactive oxygen 
species (ROS) load present in cancer cells 
compared to normal cells, which damages free 
nucleotides. MTH1 was proposed to be a good 
target for specifically targeting cancer cells and 
several potent small molecule MTH1 inhibitors 
were developed (6,8). Interestingly, not all 
developed inhibitors of MTH1 have the same 
cellular effect and a growing body of evidence 
suggests that MTH1 has other cellular roles in 
addition to sanitizing the oxidized nucleotide pool 
(7,9). We recently reported that human MTH1, in 
addition to hydrolyzing oxidized purine 
nucleoside triphosphates, also is a highly efficient 
catalyst of O6-methyl-dGTP hydrolysis (10). This 
prompted us to test other methylated nucleotides 
as MTH1 substrates and we here present N6-
methyl-dATP and N6-methyl-ATP as novel 
substrates for MTH1. We show that human 
MTH1 effectively catalyzes the hydrolysis of N6-
methyl-dATP to N6-methyl-dAMP and also 
catalyzes N6-methyl-ATP hydrolysis, albeit at a 
lower rate. This N6-methyl-dATP hydrolysis 
activity was present in all the animal MTH1 
homologues we tested, ranging from zebrafish to 
humans. Furthermore, we demonstrate that N6 
methyl-dATP present in the nucleotide pool is 
incorporated into DNA in vivo in an MTH1 
dependent manner. Since N6-methylation of 
adenine has been described to affect gene 
expression in eukaryotic cells (11), as well as to 
influence RNA processes such as transcription, 
splicing, translation and stability (12), we 
speculate that this novel MTH1 activity may help 
to safeguard against dysregulation of the cellular 
epigenome and epitranscriptome. This study 
expands the substrate collection of human MTH1 
and emphasizes the importance of MTH1 in 
sanitizing the nucleotide pool by catalyzing the 




MTH1 catalyzes the hydrolysis of N6-methyl-
dATP to N6-methyl-dAMP 
The results of HPLC- and MS-analysis of 
reaction products after MTH1 incubation with 
N6-methyl-dATP over differing lengths of time, 
show that MTH1 catalyzes the hydrolysis of N6-
methyl-dATP to N6-methyl-dAMP and inorganic 
pyrophosphate (PPi) (Figure 1A). The amount of 
formed N6-methyl-dAMP increases in a time 
dependent manner (Figure 1B,C), with the loss of 
PPi clearly observed by detection of the mass of 
N6-methyl-dAMP. N6-methyl-dATP was found 
to be stable over time under the reaction 
conditions used, with no detected hydrolysis 
observed in the absence of enzyme for up to at 
least 6 hours. To further evaluate the activity of 
MTH1 with N6-methyl-dATP we determined the 
specific activities of MTH1 with 50 µM dATP, 
N6-methyl-dATP, ATP and N6-methyl-ATP. We 
found the specific activity with N6-methyl-dATP 
to be approximately 20-fold higher than the 
activity with nonmethylated dATP (Figure 2). 
MTH1 also displays a low but measurable activity 
with N6-methyl-ATP while no detectable activity 
with ATP was observed. The specific activity 
with N6-methyl-ATP is approximately 11 times 
lower than the activity with N6-methyl-dATP 
showing that MTH1 clearly prefers 
deoxyribonucleotides over ribonucleotides as 
substrates. Hydrolysis of the selected nucleotides 
was tested at two different MTH1 concentrations, 
showing a clear dependence of substrate 
hydrolysis on MTH1 concentration 
 
MTH1 is an efficient catalyst of N6-methyl-
dATP hydrolysis 
Substrate saturation curves of MTH1 were 
generated for dATP, N6-methyl-dATP, N6-
methyl-ATP, dGTP and O6-methyl-dGTP 
(Figure 3A and B) at close to physiological pH 
(pH 7.5), and kinetic parameters were determined 
(Table 1). Addition of the N6 methyl group to 
dATP increases the catalytic efficiency (kcat/Km) 
approximately 17-fold. Similarly, methylation of  
dGTP at the O6 position increases the kcat/Km-
value considerably. It is difficult to estimate the 
effect of N6-methylation on kcat- and Km-values 





































due to no substrate saturation in the concentration 
range used. However, it is likely that the Km-value 
of MTH1 for dATP is higher than 200 µM, which 
was the highest dATP concentration used and 
which was still located in the linear part of the 
saturation curve. Consequently, the Km-value for 
dATP is likely to be at least one order of 
magnitude higher than the Km-value for N6-
methyl-dATP. The kcat-value of MTH1 with N6-
methyl-dATP (2.0 s-1) is 2.7-fold lower compared 
to the kcat-value of MTH1 with O6-methyl-dGTP 
(5.4 s-1) but 2-fold higher than the kcat-value for 
dGTP (1.0 s-1). The Km-value of MTH1 is 
approximately 2.5 times lower for O6-methyl-
dGTP compared to that for N6-methyl-dATP. 
This results in a kcat/Km-value for O6-methyl-
dGTP that is approximately 6-fold higher 
compared to N6-methyl-dATP. This may partly 
be attributable to the lower Km-value of MTH1 for 
dGTP compared to dATP, which may reflect a 
higher affinity for guanine compared to adenine. 
No substrate saturation was obtained with N6-
methyl-ATP in the concentration range used, 
meaning the determination of kcat and Km was not 
possible. However, the kcat/Km-value was 
determined from the slope of the linear part of the 
saturation curve to be 4100 M-1s-1. This value is 
more than one order of magnitude lower than the 
corresponding value for N6-methyl-dATP, 
strongly supporting a preference of MTH1 for 
deoxyribonucleotides over ribonucleotides. 
Altogether, the kinetic analysis demonstrates that 
methylation of both N6 of dATP and O6 of dGTP 
greatly improves them as MTH1 substrates and 
that this enzyme catalyzes the hydrolysis of these 
methylated substrates with high catalytic 
efficiency. This result shows that the active site of 
MTH1 has the capability to accommodate N6-
methylated dATP and O6-methylated dGTP in 
addition to the previously described oxidatively 
modified adenosine and guanine nucleoside 
triphosphates (13,14). 
 
N6-methyl-dATP activity is unique to MTH1 
amongst closely related NUDIX enzymes 
NUDT15, NUDT17, NUDT18, NUDT5 and 
NUDT14 group together with MTH1 in the 
phylogenetic tree of NUDIX proteins (15-17). 
MTH1, NUDT15 and NUDT18 cluster together 
when performing a hierarchical clustering of 
substrate activities of human NUDIX enzymes 
(17). Since these enzymes may share substrates, 
the activities of MTH1, NUDT15, NUDT17 and 
NUDT18 with N6-methyl-dATP and dATP, were 
tested. MTH1 was the only enzyme that displayed 
activity with N6-methyl-dATP among the 
enzymes tested using both 20 nM and 200 nM of 
enzyme (Figure 4). We also tested the capability 
of NUDT5 and NUDT14 to hydrolyze N6-
methyl-dATP into N6-methyl-dADP at 20 nM 
and 200 nM but no hydrolysis activity was 
observed (Supplementary Figure 1A). General 
activities of NUDT5, NUDT14, NUDT15, 
NUDT17 and NUDT18 were tested  in parallel 
with established substrates (16-21), showing that 
the proteins used for these experiments were of 
high quality (Supplementary Figure 1 B-E). 
 
Activity of MTH1 with N6-methyl-dATP is 
evolutionarily conserved 
To understand if the high activity of human 
MTH1 with N6-methyl-dATP is unique to 
humans or is also present in NUDT1 homolouges 
from other species, we tested the activity of 
NUDT1 enzymes from humans (hMTH1), dogs 
(clNUDT1), pigs (ssNUDT1), rats (rnNUDT1), 
mice (mmNUDT1), zebrafish (zfNUDT1), the 
plant Arabidopsis thaliana (atNUDT1) and E. coli 
MutT. At 50 µM N6-methyl-dATP and at a pH 
close to physiological (pH=7.5) all tested NUDT1 
enzymes apart from E. coli MutT and atNUDT1 
displayed notable activity towards N6-methyl-
dATP (Figure 5). This suggests that N6-methyl-
dATP activity has been conserved through the 
evolution of vertebrates and is likely to have been 
present in the last common ancestor of bony fish 
and more developed vertebrates present more than 
350 million years ago (22). To analyse the 
sequence similarity between the distantly related 
MutT homologues we performed an amino acid 
sequence alignment of hMTH1, E. coli MutT, 
zfMTH1 and atNUDT1 based on their crystal 
structures. The sequence alignment reveals a high 
sequence identity between hMTH1 and zfMTH1 
(70.8%) despite these enzymes being from 
distantly related organisms (Supplementary 
Figure 2A).    
 
MTH1 - N6-methyl-dAMP complex structure 
and comparison to other MTH1 structures 
To determine the binding mode of N6-
methyl-dATP in the active site of MTH1, co-
crystals of the nucleotide with hMTH1 were 
grown. The structure was solved to 2.45 Å 
resolution (Supplementary Table 1) and the 
overall structure is shown in Figure 6A. 
Coordinates and structure factors can be found in 
the Protein Data Bank with accession number 





































for N6-methyl-dAMP (Figure 6B), indicating that 
hydrolysis of N6-methyl-dATP to the 
monophosphate form occurred during co-
crystallization. The protein crystallized with four 
monomers in the asymmetric unit (chains A, B, C 
and D). In the existing crystal form, the D-chain 
appears less ordered with slightly poorer electron 
density compared to the other monomers. The 
structure contains several sulfate molecules which 
are a result of the LiSO4 present in the 
crystallization buffer. Comparison of our 
structure with apo hMTH1 (PDB ID: 3ZR1) 
resulted in low r.m.s.d values of 0.28-0.32 Å for 
the main-chain Cα-atoms, indicating that the 
overall structures are virtually identical, with no 
structural changes induced upon ligand binding. 
The nucleotide binding pocket of hMTH1 is 
comprised of a large number of hydrophobic 
amino acids including Phe27, Phe72, Phe74, 
Met81, Trp117 and Phe139 (Figure 6B). The 
purine ring system of N6-methyl-dAMP is 
positioned by pi-stacking interactions involving 
Trp117 and Phe72 and two hydrogen bonds with 
residue Asp119, which also makes a weak 
interaction (3 Å) with nearby Asp120. Asn33 
interacts weakly with the adenine base and the 
deoxyribose moiety of N6-Methyl-dAMP as 
indicated by the longer bond distances of 3.4-3.5 
Å. The deoxyribose group is further positioned by 
a hydrogen bond (2.5 Å) with the main chain 
carbonyl oxygen of Thr8. There are no hydrogen 
bond interactions between the protein binding 
pocket residues and phosphate group of the 
nucleotide (Figure 6B). The two aspartate 
residues Asp119 and Asp120 in the hMTH1 
active site have been shown to be important for 
MTH1 being able to bind the substrates 8-oxo-
dGTP and 2-oxo-dATP (23), as well as the 
reaction products 8-oxo-dGMP (24) and O6-
methyl-dGMP (10). In contrast to these 
previously solved structures, where both Asp119 
and Asp120 interact with the modified 
nucleotides through hydrogen bonds, only 
Asp119 makes direct hydrogen bond interactions 
to the nucleotide base in the MTH1 structure with 
N6-methyl-dAMP, with no atom of the nucleotide 
base of N6-methyl-dAMP within hydrogen 
bonding distance of Asp120 (Figure 7A). When 
comparing the MTH1 structure in complex with 
N6-methyl-dAMP to the structures with 2-oxo-
dATP (PBD-ID: 5GHJ), 8-oxo-dGMP (PDB-ID: 
3ZR0) and O6-methyl-dGMP (PDB-ID: 5OTM) 
these bases are shifted closer (0.53, 0.96 and 0.35 
Å, respectively) to Asn33 relative to the 
nucleotide base of N6-methyl-dAMP (Figure 7A-
D, Supplementary Figure 3). The lack in 
capability to form additional hydrogen bonds with 
Asp120 and Asn33 like the other modified 
nucleotides (Figure 7A-D) may explain the 2.5-
fold higher Km-value observed for N6-methyl-
dATP compared to O6-methyl-dGTP (Table 1). 
The hydrophobic interaction between MTH1 and 
the N6-methyl group of N6-methyl-dAMP pulls 
the base closer towards the hydrophobic sub 
pocket, as is also observed for O6-methyl-dGMP 
(10). This hydrophobic interaction causes 
identical binding modes of O6-methyl-dGMP and 
N6-methyl-dAMP, despite their dramatically 
different hydrogen bonding patterns 
(Supplementary Figure 3) indicating that this 
interaction makes a major contribution to the 
affinity for these substrates. In the structures with 
8-oxo-dGTP and 2-oxo-dATP (23) the 
protonation state of Asp119 and Asp120 switches, 
depending on the bound substrate (Figure 7). The 
protonation states of Asp119 and Asp120 in the 
N6-methyl-dAMP complex cannot be definitively 
stated. However, Asp119 is likely to be 
protonated in order to interact with the N6-methyl 
group of the ligand as well as a nearby nitrogen 
from the purine ring, whereas the protonation 
state of Asp120 is more ambiguous. In the 
interaction between Asp119 and Asp120 the 
proton could potentially be provided by either 
amino acid (Figure 7).  
 
Substrate preference of MTH1 explained by 
structure analysis  
The catalytic efficiency of MTH1 for 
hydrolysing N6-methyl-dATP is considerably 
higher than for N6-methyl-ATP (Figure 3A and 
Table 1). The additional 2-hydroxyl group of a 
ribose moiety would be directed towards Leu9 
and Val83, presenting an unfavorable 
hydrophobic environment for this group and 
likely contributing to the difference in MTH1 
activity between N6-methyl-dATP and N6-
methyl-ATP (Supplementary Figure 4). The clear 
substrate preference of MTH1 for N6-methyl-
dATP over dATP can be explained by the 
hydrophobic active site subpocket, made up by 
Phe72, Phe74 and Phe139 (Figure 6B and 
Supplementary Figure 5A and B), which provides 
favorable hydrophobic interactions with the 
methyl group of N6-methyl-dATP. For dATP 
which has a primary amine at the equivalent 
position such a hydrophobic environment would 
be less favored, which may be reflected in our 
kinetic results that show dATP is a considerably 






































N6-methyl-dATP DNA incorporation is 
prevented by MTH1 
To analyse if N6-methyl-dATP is 
incorporated into DNA and whether this is 
prevented by MTH1, we used CrispR-Cas9 to 
delete the mth1 gene and generate a homozygous 
MTH1KO zebrafish strain. Successful depletion 
was confirmed using sequencing. Fertilized 
MTH1WT and KO zebrafish eggs were 
microinjected with N6-methyl-dATP or left 
untreated. Both MTH1WT and KO zebrafish 
embryos tolerated the N6-methyl-dATP injection 
well with the same level of survival as noninjected 
embryos (Supplementary Figure 6A). We 
extracted DNA from untreated and microinjected 
WT and MTH1KO zebrafish embryos and 
analyzed the N6-methyl-dA content using LC-
MS/MS. O6-methyl-dG levels were analysed as a 
control. The N6-methyl-dA DNA levels of 
MTH1KO and MTH1WT microinjected with N6-
methyl-dATP were normalized to the N6-methyl-
dA DNA levels of untreated MTH1KO and 
MTH1WT zebrafish, respectively (Figure 8). The 
DNA of MTH1KO zebrafish microinjected with 
N6-methyl-dATP contained an approximately 
two-fold higher relative level of N6-methyl-dA 
compared to the MTH1WT zebrafish 
microinjected with N6-methyl-dATP. This 
demonstrates that MTH1 prevents the 
incorporation of N6-methyl-dATP from the 
nucleotide pool into the DNA.  When comparing 
absolute levels of N6-methyl-dA (determined as 
number of N6-methyl-dA per million nucleotides: 
MdN), N6-methyl-dATP microinjected 
MTH1KO zebrafish embryos displayed an 
approximately two-fold higher N6-methyl-dA 
level compared to untreated MTH1KO zebrafish 
embryos (Supplementary Figure 6B). In contrast, 
no difference in N6-methyl-dA DNA levels was 
observed between untreated and N6-methyl-dA 
microinjected MTH1WT zebrafish embryos 
(Supplementary Figure 6C). Interestingly, we 
observed a higher basal level of N6-methyl-dA in 
the DNA of untreated MTH1WT zebrafish 
embryos compared to untreated MTH1KO 
zebrafish embryos (Supplementary Figure 6B and 
C). This observed difference may be due to a 
difference in the developmental stage of the 
zebrafish embryos caused by the lack of 
functional MTH1, which is reflected in different 
basal levels of N6-methyl-dA in the DNA at the 
time point of harvesting. Such changes in N6-
methyl-dA levels during development have 
previously been observed in the Drosophila fly 
(25). Further studies of the MTH1 knockout 
zebrafish will be needed to definitively conclude 
if this occurs in zebrafish. As expected, no 
difference in the DNA level of O6-methyl-dG in 
the different treatment groups was observed 
(Supplementary Figure 6D). Altogether, this 
suggests that N6-methyl-dATP present in the 
nucleotide pool is able to be incorporated into 
DNA and that this can be prevented by MTH1.  
 
Discussion 
We have identifed N6-methyl-dATP as a 
novel substrate of MTH1 and show that MTH1 
can also catalyse the hydrolysis of N6-methyl-
ATP, albeit with a lower catalytic efficiency. 
Human MTH1 efficiently converts N6-methyl-
dATP to N6-methyl-dAMP, preventing its 
incorporation into DNA. Comparative N6-
methyl-dATP activity analyses of MTH1 
homologues from a variety of vertebrate species 
show that the N6-methyl-dATP activity has been 
conserved through the evolution of vertebrate 
animals suggesting this activity is important to the 
cell.  
For these novel MTH1 activities to be of 
biological significance these substrates have to be 
present in the cell, which raises the question of 
how and when N6-methyl-dATP and N6-methyl-
ATP are produced in the cell. Potential routes for 
formation of N6-methyl-dATP and N6-methyl-
ATP are depicted in Figure 9. One source of N6-
methylated adenine is the degradation of N6-
methylated RNA and DNA that would give rise to 
N6-methyl-(d)AMP (26). N6-methyl-(d)ATP 
may potentially be generated through the 
nucleotide salvage pathway through the concerted 
actions of nucleotide kinases. Adenine N6-
methylation plays an important role in post-
transcriptional mRNA processing and is the most 
abundant modification found in mammalian 
mRNA, making up 80% of the methylations of 
mRNAs with an estimated frequency of 3-5 N6-
methylated adenines per transcript (27). N6-
methylation also occurs on ribosomal RNA, 
transfer RNA and small nuclear RNA (27-29). 
Another potential route for N6-methyl-dATP and 
N6-methyl-ATP production is direct nonspecific 
methylation of dATP and ATP and other 
adenosine nucleotides via S-adenosylmethione 
(SAM) nonenzymatically or catalyzed by methyl 
transferases such as N6AMT1 and METTL3 
(11,30), that normally act on adenine in RNA and 





































Another interesting question is what 
relevance the N6-methyl-(d)ATP activity of 
MTH1 would have for the cell. N6-methylation of 
adenine is an established epigenetic marker in 
prokaryotes and has recently been reported to also 
have a similar function in eukaryotes (30-35). 
However, since the levels of N6-methyl-dA in 
eukaryotic DNA are low and are sometimes 
below the detection level of conventional LC-MS 
techniques (36) there is some controversy in the 
research field regarding the epigenetic role of N6-
methyl-dA in eukaryotes. Recently, the 
development of SMRT sequencing of chromatin 
immunoprecipitation enriched DNA has  enabled 
the detection of N6-methyl-dA in vertebrate DNA 
(30,37) and several studies suggest that N6-
methyl adenine modification in DNA constitutes 
a second layer of epigenetic regulation, alongside 
cytosine methylation (38). Changes in N6-
methylation levels in genomic DNA have been 
shown to have a major impact on diverse 
processes such as tumorigenesis (30,32), 
development (25), cell differentiation, 
maintenance of cell type and stress response 
(25,33,37,39,40). The association between 
changes in N6-methyl-dA levels and disease 
suggests that N6-methyl-dA is a biologically 
relevant DNA modification despite its evidently 
low abundance in eukaryotes. This implies that it 
is likely crucial for the cell to be able to tightly 
control the level of N6-methyl-dA as well as its 
precise locations in the genome for proper cell 
function (37).  Indeed, N6-methylation of adenine 
in human DNA is regulated by the actions of the 
methyl transferase N6AMT1 and ALKBH1 
demethylase (11,30). Due to the low DNA levels 
of N6-methyl-dA even a microevent in N6-
methyl-dA base modification, for example 
through incorporation of N6-methyl-dATP into 
the DNA during replication or DNA repair, may 
have notable consequences for the cell by 
disturbing the regulation of gene expression. We 
show through performing in vivo experiments 
using zebrafish that N6-methyl-dATP is used as a 
substrate for eukaryotic DNA polymerases during 
replication and that it is incorporated into DNA, 
which confirms what previously has been shown 
in in vitro experiments (41). The significant 
effects of alterations in DNA levels of N6-methyl-
adenine reported in the litterature suggests that it 
is likely important for the cell to remove N6-
methyl-dATP from the nucleotide pool and 
thereby prevent its incorporation into DNA.  
MTH1 also displays a low but detectable 
activity with N6-methyl-ATP (Figure 2,3 and 
Table 1). Even though this activity is considerably 
lower than for N6-methyl-dATP it cannot be 
excluded that it is still of some relevance, since 
the cellular concentration of ATP is several orders 
of magnitude higher than the concentration of 
dATP (42). Consequently, direct nonspecific 
methylation of ATP and dATP would produce 
more N6-methyl-ATP compared to N6-methyl-
dATP. N6-methylation of RNA affects many 
processes such as transcription, splicing, 
translation and stability and has been termed “the 
epitranscriptome” (12). N6-methylated RNA has 
also been shown to play roles in carcinogenesis 
and the determination of stem cell fate (28,43,44). 
Since N6-methyl-ATP is a substrate for 
eukaryotic RNA polymerases (26), MTH1 
catalyzed removal of N6-methyl-ATP present in 
the nucleotide pool would potentially help to 
avoid dysregulation of this “epitranscriptome” by 
preventing N6-methyl-ATP incorporation into 
RNA.                                                                           
The activity with N6-methyl-dATP is unique 
to MTH1 amongst human NUDIX enzymes 
(Figure 4 and Supplementary Figure 1). Similarly, 
MTH1 was found to be the only human NUDIX 
enzyme that catalyzes the hydrolysis of O6-
methyl-dGTP (10), suggesting that MTH1 is the 
sole enzyme responsible for sanitizing the 
nucleotide pool from methylated nucleoside 
triphosphates. The conversion of N6-methyl-
dATP and N6-methyl-ATP to their corresponding 
monophosphates via MTH1 catalyzed hydrolysis 
would enable further conversion to inosine 
monophosphate and deoxyinosine mono-
phosphate through deamination reactions 
catalyzed by adenosine deaminase-like protein 
isoform 1 (ADAL1) (Figure 9). ADAL1 has been 
shown to catalyze the hydrolysis of both N6-
methylated adenine and O6-methylated guanine 
nucleotides with similar efficiency independent of 
whether the sugar moiety is a ribose or a 
deoxyribose (45,46). Since MTH1 also catalyzes 
the hydrolysis of O6-methyl-dGTP and O6-
methyl-GTP (10), MTH1 and ADAL1 may act in 
concert to sanitize the nucleotide pool from 
methylated nucleotides and together convert O6-
methyl-(d)GTP and N6-methyl-(d)ATP to the 
nontoxic nucleotides (d)GMP and (d)IMP, 
respectively, which can then enter the salvage 
pathway (Figure 9).                                              
We found that unlike MTH1 of animal origin, 
the bacterial enzyme E. coli MutT and the 
NUDT1 enzyme from the plant Arabidopsis 
thaliana do not display any activity towards N6-





































the the active site hydrophobic sub-pocket that 
accommodates the methyl group of N6-methyl-
dATP shows that all NUDT1 homologues that 
catalyze the hydrolysis of N6-methyl-dATP have 
a phenylalanine residue in the position that 
corresponds to position 72 in the human enzyme 
(Phe72). A sequence alignment of hMTH1, E. coli 
MutT, zfMTH1 and atNUDT1 (Supplementary 
Figure 2A) shows that while both hMTH1 and 
zfMTH1 have a phenylalanine in this position 
(Supplementary Figure 2B), this site is occupied 
by a tyrosine (Tyr73) in E. coli MutT and by an 
asparagine (Asn76) in atNUDT1 (Supplementary 
Figure 2C and 2D), both being hydrophilic amino 
acids. Having a hydrophilic amino acid in this 
position presumably decreases the affinity for the 
methylated substrate and may at least in part 
explain the poor N6-methyl-dATP activity 
observed for E. coli MutT and atNUDT1. 
However, it may be the case that other Nudix 
enzymes present in E. coli and Arabidopsis 
thaliana not included in this study have the 
capability to hydrolyze N6-methyl-dATP. In 
bacteria it would be especially advantageous to 
have an enzyme that sanitizes N6-methyl-dATP 
from the nucleotide pool, since N6 methylation of 
adenine is the main epigenetic mark in bacteria 
and is known to affect many biological processes 
(31,47,48). A potential candidate for this activity 
in E. coli is NudB, which displays activity with 
both canonical and oxidized dATP (1).  
In summary, we have shown that N6-methyl-
dATP is a novel MTH1 substrate and that N6-
methyl-dATP present in the nucleotide pool is 
incorporated into DNA in an MTH1 dependent 
manner. Since N6-methyl-dA has been proposed 
to be an epigenetic marker, MTH1 catalyzed 
hydrolysis of N6-methyl-dATP may help to 
protect the epigenetic state of the cell. This 
expands the substrate collection of MTH1 and 
highlights the importance of MTH1 in cleansing 
the nucleotide pool from modified nucleotides, 
preventing incorporation of both oxidized and 
methylated nucleotides into DNA. 
 
Experimental procedures 
Analysis of nucleotide samples using HPLC-MS  
To analyse the MTH1 catalyzed N6-methyl-
dATP hydrolysis reaction in detail, N6-methyl-
dATP (1 mM) was incubated with 20 nM MTH1 
at 22 °C for 2.5, 5, 10, 20, 30, 40 min in MTH1 
reaction buffer (100 mM Tris Acetate pH 8.0, 40 
mM NaCl, 10 mM Magnesium Acetate). A 
sample without added MTH1 was included (0 
min). The reactions were stopped at the indicated 
time points through heat inactivation of MTH1 by 
incubating samples at 95 °C for 10 min followed 
by centrifugation at 20,000g for 10 min to remove 
the denatured protein by precipitation. Reaction 
mixture was diluted to 300 µM nucleotide with 
dH2O. Samples were analysed using HPLC-MS 
utilizing an Agilent 1100 HPLC system equipped 
with a Hypercarb column (100 mm x 2.1 mm, 
Thermo Scientific) connected to an Agilent MSD 
mass spectrometer. H2O (containing 10 mM 
NH4HCO3 pH=10) and Acetonitrile were used as 
mobile phases at a flow rate of 0.5 ml/min. The 
reaction mixture was separated using a gradient of 
10-25 % Acetonitrile and a gradient time of 6.0 
min. UV light absorbance in the 180−305 nM 
range was used for detection and masses were 
determined using electrospray ionization MS. To 
assess the stability the N6-methyl-dATP sample 
without added MTH1 (T=0 min) was rerun after 
incubation for 6 h at ambient temperature.  
 
Production of enzymes                                   
MTH1 was expressed in E. coli and purified 
as earlier described (24).  NUDT15, NUDT17 and 
NUDT18 were produced as described in (21). 
NUDT14 and NUDT5 were generated as 
described in (17). NUDT1 from rat (rnNUDT1), 
dog (clNUDT1), pig (ssNUDT1) and mouse 
(mmNUDT1) were expressed and purified as 
reported in (49) and MTH1 from zebrafish 
(zfMTH1) as described in (50). E. coli MutT was 
produced as described in (6) and NUDT1 from the 
plant Arabidopsis thaliana (atNUDT1) as 
performed in (51). 
 
MTH1 activity assay                                                                       
Activity of MTH1 (5 nM or 1 nM) with 50 
µM dATP (Promega), N6-methyl-dATP (Jena 
Bioscience), ATP (Promega) and N6-methyl-
ATP (Jena Bioscience) was assayed in MTH1 
reaction buffer (Tris-Acetate pH 8.0, 40 mM 
Sodium Chloride, 10 mM Magnesium-Acetate). 
The reaction time was 30 min and assay buffer 
was fortified with E. coli pyrophosphatase 
(PPase) (0.2 U/ml) to generate inorganic 
phosphate (Pi) from formed pyrophosphate (PPi). 
Pi was detected by addition of Malachite green 
reagent (52) followed by measurement of the 
absorbance at 630 nm using a Hidex plate reader. 
Controls without MTH1 but with PPase were 
included and the absorbance of control reactions 
was subtracted from absorbance values of assay 





































standard curve was included on each assay plate 
enabling determination of the concentration of Pi 
in the wells. 
 
Kinetic characterization of MTH1 with N6-
methyl-dATP and other substrates              
Initial rates of hydrolysis of dATP, N6-
methyl-dATP, N6-methyl-ATP, dGTP and O6-
methyl-dGTP into the corresponding mono-
phosphate and PPi, were determined in MTH1 
reaction buffer (0.1 M Tris-Acetate pH 7.5, 40 
mM Sodium Chloride, 10 mM Magnesium-
Acetate). Substrate concentrations used ranged 
from 0 to 200 µM for dATP and O6-methyl-
dGTP, from 0 to 300 µM for N6-methyl-dATP, 
N6-methyl-ATP and dGTP. The MTH1 
concentration was 1.25 nM apart from in the assay 
with N6-methyl-ATP activity where 10 nM 
MTH1 was used. Formed PPi was detected using 
PPiLightTM Inorganic Pyrophosphate Assay 
(Lonza) according to the manufacturer’s 
recommendations. A PPi standard curve on the 
assay plate was used to calculate the amount of 
PPi produced. Initial rates were determined in 
triplicate and each saturation curve experiment 
was performed at least three times. For 
determination of kinetic parameters, the 
Michaelis-Menten equation was fitted to the 
initial rate data using GraphPad Prism.  
 
Assessment of N6-methyl-dATP activity of 
human NUDIX hydrolases 
Activities of 20 and 200 nM human NUDIX 
enzyme (MTH1, NUDT15, NUDT17 and 
NUDT18) were assayed with 50 µM N6-methyl-
dATP or dATP in MTH1 reaction buffer (Tris-
Acetate pH 8.0, 40 mM Sodium Chloride, 10 mM 
Magnesium-Acetate) by incubation with shaking 
at 22 °C for 20 min. 0.2 U/ml PPase was included 
in the assay mixture to convert produced PPi to Pi, 
which was detected by addition of Malachite 
green reagent after incubation with shaking at 22 
°C followed by absorbance measurement at 630 
nm after 15 min. NUDT5 and NUDT14 (20 nM 
and 200 nM) were tested for hydrolysis activity of 
N6-methyl-dATP (50 µM) into N6-methyl-dADP 
in MTH1 reaction buffer by incubation with 
shaking for 30 min at 22 °C. To assure high 
protein quality, the activity of NUDT5 and 
NUDT14 with their known common substrate 
ADP-ribose (ADPR) was measured in parallel by 
incubating 20 nM enzyme with 50 µM ADPR in 
MTH1 reaction buffer pH 8.0 with 10 U/ml 
bovine intestinal phosphatase (BIP), which 
cleaves off the 5’-phosphate of 5’-phosphoribose 
formed upon hydrolysis of ADPR. Formed Pi was 
detected using Malachite green reagent as 
described above. To assess the general activities 
of NUDT15 and NUDT17, activities with 100 µM 
dGTP and 2-OH-dATP, respectively, using 0, 5 
and 50 nM NUDT15 or 0, 25 and 250 nM 
NUDT17, along with 0.2 U/ml E. coli PPase, were 
assayed. Activity of NUDT18 with 100 µM 8-
oxodGDP was assayed using 0, 25 and 250 nM 
enzyme. Produced Pi was detected using 
Malachite green reagent after incubation of 
NUDT15, NUDT17 and NUDT18 with respective 
substrate at 22 °C for 30 min in the same MTH1 
reaction buffer as used for assessment of N6-
methyl-dATP activity.  
 
Determination of N6-methyl-dATP activity 
among NUDT1 enzymes from different species 
NUDT1 enzyme from human (hMTH1), dog 
(clNUDT1), pig (ssNUDT1), rat (rnNUDT1), 
mouse (mmNUDT1), zebrafish (zfNUDT1), 
Arabidopsis thaliana (atNUDT1) and E. coli (E. 
coli MutT) (1.25 nM) was incubated with 50 µM 
N6-methyl-dATP (Jena BioScience) in MTH1 
reaction buffer (0.1 M Tris Acetate pH 7.5, 40 
mM Sodium Chloride, 10 mM Magnesium 
Acetate) and 0.4 U/ml PPase for 20 min at 22 °C 
in wells of clear 384 well plates, in quadruplicate. 
Pi was detected using Biomol green (Enzo Life 
Sciences). Absorbance at 630 nm was read after 
20 min. A Pi standard curve was included on the 
plate to convert signal to Pi concentration 
 
Crystallization and structure determination  
Purified hMTH1 (10.7 mg/mL) was pre-
incubated with 5 mM N6-methyl-dATP and 10 
mM MgCl2. Sitting drop vapour diffusion 
experiments were carried out at 20 °C, where 
hMTH1 (stored in 20 mM HEPES pH 7.5, 150 
mM NaCl, 5 % glycerol (v/v) and 0.5 mM TCEP) 
was mixed in a 2:1 ratio with reservoir solution 
(0.1 M sodium acetate pH 3.5, 26 % PEG3350 
(w/v) and 0.2 M LiSO4). Protein crystals were 
added briefly to a cryoprotectant solution 
consisting of the growth solution supplemented 
with 5 mM N6-methyl-dATP and 10 % glycerol, 
before being flash frozen in liquid nitrogen. X-ray 
diffraction data was collected at station I04 of the 
Diamond Light Source (Oxon, UK) equipped 
with a PILATUS-6M detector. A total of 360° of 





































1.07 Å using an oscillation angle of 0.1° and an 
exposure time of 0.02 s per image. Data reduction 
and processing were carried out using xia2 (53), 
DIALS (54) and Aimless (55) within the CCP4 
suite (56). It was evident following data collection 
and processing that the crystals suffered from 
significant anisotropy and the resolution was 
therefore cut to 2.45 Å resolution. Molecular 
replacement was performed in Phaser (57) using 
the apo structure of human MTH1 (PDB ID: 
3ZR1) as the search model. Several rounds of 
manual model building and refinement using Coot 
(58) and Refmac5 (59) were performed, during 
which waters and ligands were incorporated into 
the structure. Data collection and refinement 
statistics can be found in Supplementary Table 1. 
The structure of N6-methyl-dAMP bound 
hMTH1 has been deposited in the Protein Data 
Bank under the accession code 6QVO.  
 
Structure based comparison of NUDT1 
homologues to explain differences in activity 
A sequence alignment of hMTH1 
(UniProtKB: P36639) with E. coli MutT 
(UniProtKB: P08337), zfMTH1 (UniProtKB: 
Q7ZWC3) and AtNUDT1 (UniProtKB: 
Q9CA40) was performed using Clustal Omega 
through the EBI webserver (60). The resulting 
alignment was colored according to sequence 
similarity using BOXSHADE. The hMTH1 
residue Phe72 (PDB ID: 6QVO), an important 
residue of the hydrophobic sub-pocket that 
accommodates the methyl group of N6-methyl-
dAMP, was further compared with zfMTH1 
(PDB ID: 5OTN), AtNUDT1 (PDB ID: 6FL4) 
and E. coli MutT (PDB ID: 3A6T) in the program 
Coot (58). Pictures illustrating these 
superpositions were produced with PyMOL 
(version 2.1.1, Schrödinger). 
 
Production of MTH1 KO zebrafish  
Zebrafish lacking functional zfMTH1 
(nudt1uu1732), zfMTH1KO, were created by the 
Genome Engineering Zebrafish facility, Scilifelab 
Uppsala University, using CrispR/Cas9 
technology. Successful targeting of the MTH1 
gene by CrispR/Cas9 was confirmed by Sanger 
sequencing using 5’ TCACGTCTAAGCTGC-
TGACC-3’ and 5’- CCGCTTGCTCTATGGTC-
TCT-3’ as sequencing primers.  
 
N6-methyl-dATP injection experiments and N6-
methyl-dA LC-MS/MS analysis of DNA 
Zebrafish were housed in standard conditions 
(61). In order to investigate if N6-methyl-dATP is 
incorporated into DNA by eukaryotic DNA 
polymerases fertilized zebrafish eggs were 
microinjected with N6-methyl-dATP solution as 
described previously (50) or left untreated. 
Briefly, ∼2 nl volumes of 0.3 mM N6-methyl-
dATP in injection buffer (9 µM spermine, 0.21 
µM spermidine, 0.3% phenol red) were injected 
and eggs were distributed to plates with E3 
medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM 
CaCl2×2 H2O, 0.33 mM MgSO4). The viability of 
zebrafish embryos was assessed 24 h post 
injection and zebrafish were harvested after 32 h. 
Zebrafish DNA from the different treatment 
groups was isolated using the DNeasy Blood & 
Tissue Kit (Qiagen) according to the 
manufacturer’s recommendations and was 
analysed for N6-methyl-dA and O6-methyl-dG 
content, using LC–MS/MS. Prior to analysis, 
RNA in the DNA samples was degraded using 10 
µg RNase (Sigma-Aldrich) and incubation in 10 
mM Ammonium bicarbonate pH 7.0, 1 mM 
Magnesium Chloride, and 0.1 mM Deferoxamine 
mesylate (DFO; Santa Cruz Biotechnologies) at 
37°C for 30 min. Free nucleotides and nucleosides 
were removed using 30 kDa molecular weight 
cut-off columns (Merck) and DNA was diluted in 
UHPLC-grade water. Samples for LC-MS/MS 
were prepared by hydrolyzing up to 15 µg DNA 
in 50 µl buffer (10 mM Ammonium acetate pH 
5.5, 1 mM MgCl2, and 0.1 mM ZnCl2) using 0.8 
U nuclease P1 from P. citrinum (Sigma-Aldrich), 
80 U Benzonase® nuclease (Sigma Aldrich), and 
0.2 U Alkaline phosphatase from E. coli (Sigma-
Aldrich) at 37°C for 1 h. Reactions were stopped 
by placing the samples on ice. Proteins were 
precipitated by adding three volumes ice-cold 
Acetonitrile followed by centrifugation at 16,000 
g for 30 min. Supernatants were then lyophilized 
at -80°C. Finally, the samples were re-dissolved 
in 30 µl water, of which 5 µl was diluted 5000-
fold and used for measuring the four canonical 
nucleosides and 20 µl was used to measure 
modified nucleosides using LC-MS/MS analysis. 
Modified nucleosides were analysed using an 
Agilent 6495 triple quadrupole LC/MS/MS 
system with an Agilent EclipsePlusC18 RRHD 
column (2.1 × 150 mm, 1.8 µm particle size). The 
mobile phases used were (A) UHPLC-grade water 
and (B) UHPLC-grade methanol, both containing 
0.1% UHPLC-grade formic acid. The HPLC 
method used a flow rate of 300 µl/min with 5% B 
for 2.5 min, followed by a gradient to 13% B at 3 





































B from 5.5 to 7 min, a ramp to 5% at 8 min, and 
finally equilibration with 5% B from 7 to 11.5 
min. Unmodified nucleosides were measured on 
an API5500 triple quadrupole mass spectrometer 
(Applied Biosystems) with an Acentis® Express 
C18 column (0.5 × 150 mm, 2.7 µm particle size). 
The HPLC method used a flow rate of 150 µl/min 
with an isocratic flow of 25% B for 3 min with the 
column heated to 40°C.  
The mass transitions used were 266.1 → 150, 
282.1 → 166.1, 252.1 → 136, 228.1 → 111.9, 
268.1→152, and 243.1→127 m/z for N6-met-dA, 
O6-met-dG, dA, dC, dG, and dT, respectively. 
 
Data availability 
The protein structure presented in this paper has 
been deposited in the Protein Data Bank (PDB) 
under the accession code 6QVO. All remaining 
data are contained within the article. 
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Table 1. Kinetic parameters of MTH1 for canonical and methylated substrates              
Kinetic parameters were determined by fitting the Michaelis-Menten equation to determined initial rates 
using GraphPad Prism. Average and SD of determined kinetic parameters from several independent 



















N6-methyl-dATP 2.0 ± 0.4 40.9 ± 8.2   50,300 ± 15,700 4 
dATP - - 3,000 ± 200 3 
N6-methyl-ATP - - 4,100 ± 800 2 
dGTP 1.0 ± 0.4 154 ± 92   7,100 ± 1,900 3 







































Figure 1. MTH1 catalyzes the hydrolysis of N6-methyl-dATP. (A) MTH1 catalyzes the 
hydrolysis of N6-methyl-dATP to N6-methyl-dAMP and PPi. (B) Time course hydrolysis of 
N6-methyl-dATP (1 mM) catalyzed by MTH1 (20 nM) was monitored by separation of reaction 
samples incubated 0-40 min at 22 °C on a Hypercarb column using HPLC coupled to MS. 
Reaction substrate and product was detected at 254 nm and the mass of the product N6-methyl-
dAMP was clearly observed by mass detection. (C) Graph showing the fraction of N6-methyl-
dATP and N6-methyl-dAMP in percent after various time of hydrolysis based on the respective 














































Figure 2. MTH1 activity with N6-methyl-dATP and N6-methyl-ATP compared to dATP. Activity 
of 1 nM and 5 nM MTH1 was tested with 50 µM N6-methyl-dATP, dATP, ATP and N6-methyl-ATP 
in MTH1 reaction buffer pH 8.0 at 22 °C. Reaction time was 30 min and 0.2 U/ml PPase was used to 
generate Pi from produced PPi. Pi was detected by addition of Malachite green reagent followed by 
measurement of the absorbance at 630 nm. Controls with PPase only was included and background 
signal was subtracted from the assay data. A Pi standard curve was included on the plate enabling 
determination of the concentration of formed PPi. Graph shows means with SD from one experiment 
























































































Figure 3. Kinetic characterization of MTH1 catalyzed hydrolysis of dATP, N6-methyl-dATP, N6-
methyl-ATP, dGTP and O6-methyl-dGTP. (A) Substrate saturation curves of MTH1 (1 nM) were 
produced using MTH1 reaction buffer pH 7.5. Initial rates were determined at dATP concentrations 
varied between 0-200 µM and between 0-300 µM for N6-methyl-dATP and N6-methyl-ATP, 
respectively, and for dGTP and O6-methyl-dGTP (B) using 0-300 µM and 0-200 µM, respectively. 
Formed PPi was detected using PPiLight
 
Inorganic Pyrophosphate Assay (Lonza) and assay signal was 

































































Figure 4. Activity with N6-methyl-dATP is unique to MTH1 within human NUDIX subfamily.  
Activities of human NUDIX enzyme (MTH1, NUDT15, NUDT17 and NUDT18) were assayed with 
data points in quadruplicate with 50 µM dATP or N6-methyl-dATP at 20 and 200 nM enzyme in MTH1 
reaction buffer pH 8.0. 0.2 U/ml PPase was used to convert formed PPi to Pi that was detected using 
Malachite green reagent and measurement of absorbance at 630 nm. Graph shows means with SD from 
































































































































Figure 5. Activity with N6-methyl-dATP is evolutionary conserved among vertebrates. MutT 
homologues (MTH1, NUDT1) from different animal species as well as E. coli MutT and NUDT1 from 
the plant Arabidopsis thaliana were screened for hydrolysis activity with N6-methyl-dATP. Enzyme 
(1.25 nM) was incubated with 50 µM N6-methyl-dATP in MTH1 reaction buffer pH 7.5 with 0.4 U/ml 
PPase for 20 min at 22 °C in triplicates. Pi was detected using Biomol green (Enzo Life Sciences). 
Absorbance at 630 nm was read after 20 minutes. A Pi standard curve was included on the plate and 
used to convert assay signal to produced PPi. Data is shown as hydrolyzed N6-methyl-dATP (µM) 
divided by concentration NUDT1 enzyme (µM) per second. Graph shows means with SD from 






































































































Figure 6. Crystal structure of hMTH1 in complex with N6-methyl-dAMP. (A) Overall structure of 
hMTH1 in ribbon representation, colored blue. The Nudix motif is colored magenta. N6-met-dAMP is 
presented as a stick model. (B)The active site hydrogen bond network of hMTH1 with the reaction 




 composite omit map contoured at 
1.0 σ. Important binding residues and residues of the hydrophobic pocket are depicted as sticks; C atoms 
are colored white, O atoms red, N atoms blue and S atoms gold. N6-met-dAMP is presented as a stick 
model; C atoms are colored yellow, O atoms red, N atoms blue and P atoms orange. Hydrogen bond 
interactions are shown as dashed lines with bond distances indicated in Angstroms (Å). (C-D) 
Refinement of hMTH1 structure. The ligands (C) dAMP and (D) N6-methyl-dAMP were modelled into 
hMTH1 in Coot (58) following which the structures were refined using Refmac5 (59). The 2Fo-Fc 
electron density maps around the ligands following refinement are contoured at 1.0 σ (blue) and the Fo-
Fc electron density maps are contoured at -2.5 σ (red) and +2.5 σ (green). Figures were produced with 









































Figure 7. Schematic representation of the recognition of nucleotides by hMTH1. Hydrogen bond 
interactions of (A) N6-methyl-dAMP (N6-metA), (B) 2-oxo-dATP (2-oxoA) (23) (C) O6-methyl-
dGMP (O6-metG) (10) and (D) 8-oxo-dGMP (8-oxoG) (24). Hydrogen bonds are shown as dashed lines 
and bond distances are given in Angstroms (Å). Deprotonated aspartates which act as hydrogen bond 



















































Figure 8. N6-methyl-dATP is incorporated into DNA in an MTH1 dependent manner. DNA was 
extracted from zebrafish MTH1KO and MTH1WT embryos developed from fertilized zebrafish eggs 
microinjected with N6-methyl-dATP or left untreated. DNA was analysed for N6-methyl-dA content 
using LC-MS/MS. N6-methyl-dA content was normalised to N6-methyldA levels in untreated 
MTH1KO and MTH1WT zebrafish embryos, respectively. N6-methyl-dATP microinjected MTH1KO 
zebrafish embryos display a two-fold higher N6-methyl-dA level compared to untreated embryos while 
N6-methyl-dA DNA levels in MTH1WT zebrafish did not differ between untreated and N6-methyl-dA 
microinjected embryos. This suggests that N6-methyl-dATP is incorporated into DNA and 






































































Figure 9. Potential routes for cellular production and metabolism of N6-methyl-dATP and N6-
methyl-ATP. N6-methyl-dATP and N6-methyl-ATP may be produced from N6-methyl-dAMP and N6-
methyl-AMP formed upon DNA and RNA degradation, respectively. This may occur through the 
consecutive actions of adenylate kinase (AK) and  nucleoside diphosphate kinase or through nonspecific 
methylation by S-adenosyl-methionine (SAM), the N6-adenosine-methyltransferase METTL3 or N6 
adenine-specific DNA methyltransferase 1 (N6AMT1). N6-methyl-dATP and N6-methyl-ATP are 
hydrolysed by MTH1 to their corresponding monophosphates and further metabolized by adenosine 
deaminase-like protein isoform 1 (ADAL1) to dIMP and IMP that can then enter the nucelotide salvage 
pathway. Abbreviations used in the figure: NDPK, nucleoside diphosphate kinase; AK, Adenylate 
kinase; RNR, Ribonucleotide reductase; MTH1, MutT Homologue 1; ADAL1, Adenosine deaminase-
like protein isoform 1; METTL3, N6-adenosine methyltransferase; N6AMT1, N6-adenine-specific 
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